iRadimed Corp (IRMD)
51.08
+1.89
(+3.84%)
USD |
NASDAQ |
Nov 05, 11:32
iRadimed Gross Profit Margin (Quarterly): 77.44% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 77.44% |
| June 30, 2024 | 78.14% |
| March 31, 2024 | 76.07% |
| December 31, 2023 | 76.86% |
| September 30, 2023 | 77.78% |
| June 30, 2023 | 75.55% |
| March 31, 2023 | 75.74% |
| December 31, 2022 | 75.49% |
| September 30, 2022 | 78.63% |
| June 30, 2022 | 79.71% |
| March 31, 2022 | 76.19% |
| December 31, 2021 | 77.91% |
| September 30, 2021 | 77.06% |
| June 30, 2021 | 74.74% |
| March 31, 2021 | 76.56% |
| December 31, 2020 | 75.35% |
| September 30, 2020 | 74.57% |
| June 30, 2020 | 72.56% |
| March 31, 2020 | 74.49% |
| December 31, 2019 | 74.82% |
| September 30, 2019 | 78.24% |
| June 30, 2019 | 79.86% |
| March 31, 2019 | 75.73% |
| December 31, 2018 | 76.23% |
| Date | Value |
|---|---|
| September 30, 2018 | 76.01% |
| June 30, 2018 | 76.81% |
| March 31, 2018 | 76.20% |
| December 31, 2017 | 75.54% |
| September 30, 2017 | 77.02% |
| June 30, 2017 | 77.66% |
| March 31, 2017 | 73.12% |
| December 31, 2016 | 78.23% |
| September 30, 2016 | 81.68% |
| June 30, 2016 | 82.38% |
| March 31, 2016 | 80.97% |
| December 31, 2015 | 82.95% |
| September 30, 2015 | 80.59% |
| June 30, 2015 | 81.31% |
| March 31, 2015 | 81.00% |
| December 31, 2014 | 74.36% |
| September 30, 2014 | 74.83% |
| June 30, 2014 | 81.50% |
| March 31, 2014 | 81.55% |
| December 31, 2013 | 72.55% |
| September 30, 2013 | 72.99% |
| June 30, 2013 | 72.34% |
| March 31, 2013 | 82.23% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
72.56%
Minimum
Jun 2020
79.71%
Maximum
Jun 2022
76.28%
Average
76.13%
Median
Gross Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 84.00% |
| NovaBay Pharmaceuticals Inc | 66.33% |
| Protalix BioTherapeutics Inc | 29.82% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.18% |
| Return on Assets | 20.62% |
| Return on Invested Capital | 24.18% |
| Profit Margin (Quarterly) | 27.55% |
| Operating Margin (Quarterly) | 31.59% |
| Return on Net Operating Assets | 48.21% |